Sweeteners
Sweeteners are a subcategory of pharmaceutical active pharmaceutical ingredients (APIs) widely used in the pharmaceutical industry to enhance the palatability of medicinal products. These additives provide a pleasant taste while maintaining the desired therapeutic properties of the drug formulation.
Pharmaceutical sweeteners are primarily employed to mask the inherent bitterness or unpleasant flavors of certain medications, making them more appealing to patients, particularly children and individuals with taste sensitivities. These sweeteners are carefully selected to meet specific criteria such as safety, stability, and compatibility with other ingredients in the formulation.
There are various types of sweeteners used in pharmaceuticals, including artificial sweeteners, natural sweeteners, and sugar alcohols. Artificial sweeteners such as aspartame, sucralose, and saccharin are non-nutritive compounds that provide intense sweetness without contributing significant calories. Natural sweeteners like stevia extract and monk fruit extract are derived from plant sources and offer a more natural alternative.
In addition to their taste-enhancing properties, pharmaceutical sweeteners must adhere to stringent regulatory guidelines to ensure patient safety. Extensive testing is conducted to evaluate their toxicity, purity, and compatibility with other pharmaceutical ingredients. Furthermore, the stability of sweeteners in different storage conditions is assessed to guarantee their effectiveness over the product's shelf life.
Overall, pharmaceutical sweeteners play a crucial role in improving patient compliance and acceptability of medicinal products. Their careful selection and formulation contribute to the development of palatable and effective medications, ultimately enhancing the overall therapeutic experience for patients.
Name | CAS number | Category | Amount of suppliers |
---|---|---|---|
Aspartame | 22839-47-0 | Sweeteners | 4 |
Sucralose | 56038-13-2 | Sweeteners | 6 |
Sucrose | 57-50-1 | Sweeteners | 4 |